Stay updated on Long-term Effects of Vedolizumab Subcutaneous Clinical Trial
Sign up to get notified when there's something new on the Long-term Effects of Vedolizumab Subcutaneous Clinical Trial page.

Latest updates to the Long-term Effects of Vedolizumab Subcutaneous Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history shows the addition of Revision: v3.4.2 and the removal of the general funding notice (Revision: v3.4.1), neither of which alters trial data or core study details. These edits are related to site-wide documentation and do not impact the displayed study information or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check20 days agoChange DetectedA government funding status notice has been added and the record version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check28 days agoChange DetectedThe history view now includes a 'Show glossary' option and color-coded change highlights (green for additions, red for deletions). The revision label was updated to Revision: v3.4.0 and the capitalization of the 'No FEAR Act' text was adjusted.SummaryDifference0.7%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, replacing the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer now includes Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedA new Revision: v3.3.2 was added to the Record History and Revision: v3.2.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Long-term Effects of Vedolizumab Subcutaneous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Effects of Vedolizumab Subcutaneous Clinical Trial page.